EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation

Beatrice Rondinelli1,2, Ewa Gogola3, Hatice Yücel1

  • 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USA.

Nature Cell Biology
|October 17, 2017
PubMed

Insights

EZH2 stabilizes stalled DNA replication forks by recruiting MUS81 nuclease, a key mechanism in BRCA1/2-deficient cancers. Loss of EZH2 or MUS81 promotes resistance to PARP inhibitors (PARPi) and predicts poor patient outcomes.

Area of Science:

  • * Molecular biology
  • * Cancer research
  • * Genomics

Background:

  • * Poly-ADP-ribose polymerase inhibitors (PARPi) resistance is a major challenge in treating BRCA1 and BRCA2 (BRCA1/2)-deficient tumors.
  • * Stabilization of stalled DNA replication forks is an emerging mechanism of PARPi resistance, promoting genomic stability in these cancers.
  • * Understanding the molecular pathways governing genomic stability at stalled forks is crucial.

Purpose of the Study:

  • * To investigate the role of EZH2 in regulating genomic stability at stalled DNA replication forks.
  • * To determine the molecular mechanisms by which EZH2 influences PARPi resistance in BRCA1/2-deficient cancers.
  • * To evaluate EZH2 and MUS81 as potential biomarkers for treatment response.

Main Methods:

  • * Investigated EZH2 localization at stalled replication forks.
  • * Analyzed the impact of EZH2 on histone H3 lysine 27 trimethylation (H3K27me3) and MUS81 nuclease recruitment.
  • * Assessed the consequences of EZH2/MUS81 axis dysfunction on PARPi resistance in BRCA2-deficient cells and a murine model.
  • * Correlated EZH2 and MUS81 expression levels with clinical outcomes in patients with BRCA2-mutated tumors.

Main Results:

  • * EZH2 was found to localize at stalled replication forks and mediate the recruitment of the MUS81 nuclease via H3K27me3.
  • * Reduced EZH2 levels led to decreased H3K27 methylation, impaired MUS81 recruitment, and subsequent fork stabilization.
  • * Loss of the EZH2/MUS81 axis conferred PARPi resistance in BRCA2-deficient cells.
  • * Low EZH2 or MUS81 expression correlated with chemoresistance and poorer outcomes in patients with BRCA2-mutated tumors.
  • * Ezh2 inhibition in a murine Brca2-/- breast cancer model induced acquired PARPi resistance.

Conclusions:

  • * EZH2 is a critical regulator of genomic stability at stalled replication forks, linking histone modifications to nuclease recruitment.
  • * The EZH2/MUS81 axis is a key determinant of PARPi sensitivity in BRCA2-deficient cancers.
  • * EZH2 expression serves as a predictive biomarker for response to chemotherapy in BRCA2-deficient tumors.

Related Concept Videos

The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication forks, one in...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication forks, one in...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...